This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Australian Brain Bank Network | |
|---|---|
| Name | Australian Brain Bank Network |
| Formation | 1990s |
| Type | Biobank network |
| Headquarters | Australia |
| Region served | Australia |
Australian Brain Bank Network is a coordinated network of brain banks across Australia focused on the collection, preservation, characterization and distribution of human post-mortem brain tissue for neurological and neurodegenerative research. The Network facilitates access to well-annotated tissue and associated clinical data for researchers studying disorders such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic lateral sclerosis, Multiple sclerosis and psychiatric conditions including Schizophrenia, Bipolar disorder and Major depressive disorder. It supports translational projects linking neuropathology with imaging cohorts from institutions like Australian National University, University of Melbourne, University of Sydney, Monash University and Florey Institute of Neuroscience and Mental Health, and enables contribution to international consortia such as the Human Brain Project, International Society for Biological and Environmental Repositories and Global Alzheimer's Association Interactive Network.
The Network comprises multiple regional brain banks located in capital cities including Melbourne, Sydney, Brisbane, Perth and Adelaide and leverages clinical services at hospitals such as Royal Melbourne Hospital, Royal Prince Alfred Hospital, Royal Brisbane and Women's Hospital, Sir Charles Gairdner Hospital and Royal Adelaide Hospital. Its standard operating procedures are aligned with international guidelines from organizations like World Health Organization, National Institutes of Health and World Medical Association to ensure uniform tissue processing, neuropathological assessment, and data harmonization across sites. Specimens are linked to longitudinal clinical assessments from cohorts and studies run by groups such as Australian Imaging, Biomarkers and Lifestyle Study of Ageing, Tasmanian Longitudinal Study, Sydney Memory and Ageing Study and registries affiliated with National Health and Medical Research Council–funded programs.
Origins trace to regional initiatives in the 1990s when neuropathologists at centres including University of New South Wales, University of Queensland and University of Western Australia established local repositories integrating work by researchers associated with the Prion Unit and dementia clinics at tertiary hospitals. Formal network coordination emerged following collaborative meetings involving stakeholders from NHMRC, the Commonwealth Scientific and Industrial Research Organisation, state health services and research institutes such as Barwon Health and Hunter Medical Research Institute. Major milestones include integration of standardized neuropathological criteria from groups like the National Institute on Aging–Alzheimer's Association and participation in multicentre studies such as consortia linked to European Brain Bank Network, Alzheimer's Disease Neuroimaging Initiative and projects supported by the Michael J. Fox Foundation.
Governance incorporates academic leads from universities including University of New England, Griffith University, Deakin University and research directors from institutes such as Peter MacCallum Cancer Centre and Florey Institute. An executive committee interfaces with ethics committees at hospitals like St Vincent's Hospital and state health departments, and advisory panels include neuropathologists, neurologists and biostatisticians from centres such as Royal Prince Alfred Hospital, Austin Health and Queensland Institute of Medical Research. Data custodianship follows frameworks used by the Australian Research Data Commons and aligns with privacy principles cited by bodies like the Office of the Australian Information Commissioner.
Collections include frozen tissue, formalin-fixed paraffin-embedded blocks, cerebrospinal fluid, peripheral blood, DNA, RNA and brain-derived cell lines sourced from donors diagnosed at clinics such as Memory Clinic Royal Melbourne Hospital, Parkinson's Disease Clinic Royal Prince Alfred and psychiatric services at Prince of Wales Hospital. Regions provide regional brain region dissections (hippocampus, substantia nigra, motor cortex) processed using protocols comparable to those used at Mayo Clinic, Queen Square Brain Bank and BrainNet Europe. Each sample is accompanied by neuropathology reports referencing staging systems from groups like Braak staging and criteria from CERAD or the National Institute on Aging–Alzheimer's Association frameworks.
The Network has enabled projects linking molecular neuropathology with neuroimaging data from centres such as The Florey, Westmead Hospital and Royal Perth Hospital, collaborations with international laboratories at Columbia University, University College London, Massachusetts General Hospital, Karolinska Institutet and Max Planck Institute for Neurobiology. Research outputs span transcriptomics, proteomics and genomics using platforms developed by partners including EMBL-EBI, Broad Institute, Wellcome Trust Sanger Institute and instrumentation from Illumina, Thermo Fisher Scientific and Agilent Technologies. The Network contributes tissue to clinical translation studies associated with trials run by groups like Australian Dementia Network and pharmaceutical collaborations involving companies such as Roche, Biogen and Eli Lilly and Company.
Consent procedures follow models developed with institutional ethics committees at Monash Health, Western Sydney Local Health District and advisory guidance from bodies including the NHMRC and Australian Research Integrity Committee. Legal frameworks reference state legislation in Victoria, New South Wales, Queensland, Western Australia and South Australia concerning post-mortem donation and health information, and governance adheres to standards used by entities such as the National Blood Authority and the Human Tissue Authority in international comparison. Community engagement has collaborated with advocacy organizations including Dementia Australia, Parkinson's Australia, Motor Neurone Disease Association of Australia and consumer groups at university partner sites.
Funding derives from competitive grants from National Health and Medical Research Council, philanthropic support from foundations like the Ian Potter Foundation, collaborations with research councils including Australian Research Council, state health department infrastructure grants and project funding from partnerships with international funders such as the European Commission and private foundations including the Wellcome Trust and Bill & Melinda Gates Foundation. Industry-supported studies involve biotech and pharmaceutical partnerships with entities such as Pfizer, Novartis and venture-funded spinouts emerging from university technology transfer offices at University of Melbourne and University of Sydney.
Category:Biobanks in Australia